Groupama Asset Managment Makes New $466,000 Investment in Globe Life Inc. $GL

Groupama Asset Managment bought a new stake in shares of Globe Life Inc. (NYSE:GL) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 3,347 shares of the company’s stock, valued at approximately $466,000.

A number of other hedge funds have also recently made changes to their positions in GL. Norges Bank bought a new position in Globe Life during the 4th quarter valued at approximately $155,617,000. Northwestern Mutual Wealth Management Co. boosted its holdings in Globe Life by 34,786.0% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock worth $123,345,000 after acquiring an additional 879,391 shares in the last quarter. AQR Capital Management LLC grew its stake in shares of Globe Life by 98.6% in the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after acquiring an additional 696,548 shares during the last quarter. Balyasny Asset Management L.P. bought a new position in shares of Globe Life during the third quarter valued at $80,925,000. Finally, Arrowstreet Capital Limited Partnership increased its holdings in shares of Globe Life by 32.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock valued at $200,734,000 after acquiring an additional 355,399 shares in the last quarter. 81.61% of the stock is owned by institutional investors.

Insider Activity at Globe Life

In related news, CFO Thomas Peter Kalmbach sold 25,650 shares of the stock in a transaction that occurred on Tuesday, July 28th. The shares were sold at an average price of $178.58, for a total transaction of $4,580,577.00. Following the transaction, the chief financial officer owned 50,568 shares in the company, valued at $9,030,433.44. This represents a 33.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Frank M. Svoboda sold 20,000 shares of Globe Life stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the completion of the sale, the chief executive officer directly owned 54,020 shares of the company’s stock, valued at approximately $8,463,853.60. This trade represents a 27.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 169,174 shares of company stock valued at $28,553,849 over the last ninety days. Company insiders own 2.11% of the company’s stock.

Globe Life Trading Down 0.1%

Globe Life stock opened at $182.14 on Monday. Globe Life Inc. has a one year low of $127.85 and a one year high of $191.55. The business’s fifty day moving average is $171.52 and its 200 day moving average is $154.34. The stock has a market capitalization of $14.14 billion, a PE ratio of 12.09 and a beta of 0.48. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The business had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.Globe Life’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period last year, the firm posted $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, sell-side analysts predict that Globe Life Inc. will post 15.7 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Truist Financial upped their price target on shares of Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Friday, April 24th. Piper Sandler raised their price objective on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Jefferies Financial Group upped their target price on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. TD Cowen increased their price target on shares of Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Finally, Keefe, Bruyette & Woods reduced their price target on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a research report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Globe Life currently has an average rating of “Moderate Buy” and an average price target of $191.67.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.